Enterprise Value

564.6M

Cash

85.01M

Avg Qtr Burn

-9.06M

Short % of Float

6.77%

Insider Ownership

43.10%

Institutional Own.

51.27%

Qtr Updated

06/30/23


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date